Feb 26, 2026 03:25PM
Dec 11, 2025 04:01PM
Dec 11, 2025 04:01PM
Dec 9, 2025 11:30PM
Dec 9, 2025 11:30PM
Dec 8, 2025 04:01PM
Dec 8, 2025 04:01PM Kymera Therapeutics launches $500 million public stock offering
Dec 8, 2025 04:01PM
Aug 27, 2025 07:00AM
Jul 3, 2025 04:25AM
Jun 26, 2025 11:56PM
Jun 25, 2025 04:06PM
Jun 25, 2025 04:05PM
Jun 3, 2025 03:19AM Morgan Stanley Upgrades Kymera Therapeutics (KYMR) to Overweight
Aug 28, 2024 07:00AM
Aug 21, 2024 11:15AM
Aug 20, 2024 06:12AM
Aug 19, 2024 10:45PM
Aug 19, 2024 04:01PM
Aug 19, 2024 04:01PM
Jan 9, 2024 09:15AM Kymera Therapeutics Announces Closing of Upsized $275 Million Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
Jan 5, 2024 06:00AM
Jan 5, 2024 06:00AM
Jan 4, 2024 04:01PM
Jan 4, 2024 04:01PM
Aug 28, 2023 07:00AM
Sep 2, 2021 08:00AM
Sep 2, 2021 08:00AM Kymera Therapeutics to Present at Upcoming September Investor Conferences
Jul 6, 2021 04:00PM
Jul 6, 2021 04:00PM
Jul 1, 2021 04:48AM
Jun 30, 2021 09:45PM
Jun 30, 2021 09:45PM
Jun 28, 2021 04:39PM
Jun 28, 2021 04:36PM Kymera Therapeutics Announces Proposed Public Offering of Common Stock
Jun 28, 2021 04:36PM
Feb 25, 2021 07:00AM
Feb 25, 2021 07:00AM
Jan 19, 2021 02:23AM
Sep 15, 2020 05:49AM
Sep 14, 2020 07:00AM
Sep 14, 2020 07:00AM Kymera Therapeutics to Present at Morgan Stanley 18th Annual Global Healthcare Conference
Aug 25, 2020 04:01PM
Aug 25, 2020 04:01PM
Aug 21, 2020 05:57AM
Aug 20, 2020 08:36PM
Aug 20, 2020 08:36PM

211,042 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All